State Street SPDR S&P Biotech ETF

State Street SPDR S&P Biotech ETF is an exchange-traded fund that provides targeted exposure to U.S. biotechnology companies. It seeks to track the S&P Biotechnology Select Industry Index, using an equal-weighted approach that gives relatively balanced representation across the portfolio rather than concentrating heavily in the largest firms. The fund is designed for investors looking for broad access to the biotech segment of the healthcare market through a single security. Its holdings typically span drug developers, therapeutic innovators, life sciences tools companies, and other biotechnology businesses across different market-cap sizes. State Street SPDR S&P Biotech ETF is used by market participants to gain sector-specific exposure within healthcare, offering a diversified way to follow the performance of U.S. biotech equities within the broader financial market.